Stable Isotope Labeled Compounds Market by Type (Carbon 13, D, Oxygen 18, N15), Application (Research, Clinical Diagnostics, Industrial), End User (Pharmaceutical & Biopharmaceutical Companies, Academic institute), Region – Global Forecast to 2024

Table of Contents

1.... INTRODUCTION

1.1             OBJECTIVES OF THE STUDY
1.2             MARKET DEFINITION
1.2.1              MARKET SCOPE
1.2.2              MARKETS COVERED
1.2.3              YEARS CONSIDERED FOR THE STUDY
1.3             CURRENCY
1.4             LIMITATIONS
1.5             STAKEHOLDERS

2.... RESEARCH METHODOLOGY

2.1             RESEARCH DATA
2.2             SECONDARY DATA
2.2.1              KEY DATA FROM SECONDARY SOURCES
2.3             PRIMARY DATA
2.3.1              KEY DATA FROM PRIMARY SOURCES
2.4             MARKET SIZE ESTIMATION
2.4.1              REVENUE MAPPING-BASED MARKET ESTIMATION
2.5             DATA TRIANGULATION
2.5.1              ASSUMPTIONS FOR THE STUDY
2.5.2              LIMITATIONS

3.... EXECUTIVE SUMMARY

4.... PREMIUM INSIGHTS

4.1             STABLE ISOTOPE-LABELED COMPOUNDS MARKET OVERVIEW
4.2             NORTH AMERICA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION (2018). 33
4.3             GEOGRAPHICAL SNAPSHOT OF THE STABLE ISOTOPE-LABELED COMPOUNDS MARKET

5.... MARKET OVERVIEW

5.1             INTRODUCTION
5.2             MARKET DYNAMICS
5.2.1              DRIVERS
5.2.1.1            INCREASE IN RESEARCH ACTIVITIES IN THE PHARMACEUTICAL & BIOTECHNOLOGY SECTORS
5.2.1.2            GROWING PROTEOMICS RESEARCH
5.2.1.3            GROWING PREVALENCE OF CANCER
5.2.2              RESTRAINTS
5.2.2.1            HIGH COST OF STABLE ISOTOPE-LABELED COMPOUNDS
5.2.3              OPPORTUNITIES
5.2.3.1            GROWING INVESTMENTS IN PHARMACEUTICAL R&D IN EMERGING MARKETS
5.2.4              CHALLENGES
5.2.4.1            DEARTH OF SKILLED PROFESSIONALS

6.... STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE

6.1             INTRODUCTION
6.2             HYDROGEN-2
6.2.1              GROWING APPLICATIONS OF H-2 IN PHARMACEUTICAL RESEARCH WILL DRIVE THE DEMAND FOR LABELED COMPOUNDS
6.3             CARBON-13
6.3.1              GROWING NUMBER OF METABOLOMICS STUDIES AND APPLICATIONS IN DISEASE DIAGNOSIS ARE DRIVING MARKET GROWTH
6.4             OXYGEN-18
6.4.1              INCREASING RESEARCH ON CANCER IS EXPECTED TO DRIVE THE DEMAND FOR OXYGEN-18-LABELED ISOTOPES
6.5             NITROGEN-15
6.5.1              EXPANDING APPLICATIONS OF N-15 IN AGRICULTURAL INVESTIGATION AND RISING RESEARCH ARE LIKELY TO DRIVE MARKET DEMAND
6.6             OTHER STABLE ISOTOPES

7.... STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION

7.1             INTRODUCTION
7.2             RESEARCH APPLICATIONS
7.2.1              BIOMEDICAL RESEARCH
7.2.1.1            INCREASING NUMBER OF BIOMEDICAL RESEARCH ACTIVITIES INVOLVING STABLE ISOTOPES TO DRIVE THE STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR BIOMEDICAL RESEARCH
7.2.2              PHARMACEUTICAL RESEARCH
7.2.2.1            STABLE ISOTOPICALLY MODIFIED PHARMACEUTICAL AGENTS OFFER REDUCED SIDE-EFFECTS, IMPROVED ORAL BIOAVAILABILITY, AND INCREASED HALF-LIFE—KEY FACTORS DRIVING MARKET GROWTH
7.2.3              ENVIRONMENTAL & ECOLOGICAL RESEARCH
7.2.3.1            INCREASING USE OF STABLE TO STUDY THE FEEDING ECOLOGY OF LIVING OR EXTINCT ANIMAL SPECIES THROUGH THE ANALYSIS OF THEIR RATIOS IN CARCASSES OR REMAINS TO DRIVE MARKET GROWTH
7.2.4              AGRICULTURAL RESEARCH
7.2.4.1            INCREASING USE OF STABLE ISOTOPES TO PREVENT SOIL POLLUTION AND CONTAMINATION AND FACILITATE MAXIMUM CROP PRODUCTION TO DRIVE GROWTH IN THIS MARKET
7.3             CLINICAL DIAGNOSTICS
7.3.1              INCREASING ADOPTION OF PET SCANS AND GAMMA IMAGING FOR DISEASE STAGING TO SUPPORT MARKET GROWTH
7.4             INDUSTRIAL APPLICATIONS
7.4.1              GROWING APPLICATION OF STABLE ISOTOPES IN THE NUCLEAR INDUSTRY AND THE INCREASING NUMBER OF NUCLEAR REACTORS TO SUPPORT MARKET GROWTH
7.5             OTHER APPLICATIONS

8.... STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER

8.1             INTRODUCTION
8.2             PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
8.2.1              INCREASE IN R&D ACTIVITIES TO DRIVE THE DEMAND FOR STABLE ISOTOPE-LABELED COMPOUNDS AMONG PHARMA & BIOTECH COMPANIES
8.3             ACADEMIC & RESEARCH INSTITUTES
8.3.1              GROWING RESEARCH ON VARIOUS TREATMENT THERAPIES IS DRIVING THE GROWTH OF THIS END-USER SEGMENT. 67
8.4             HOSPITALS & DIAGNOSTIC CENTERS
8.4.1              ADOPTION OF STABLE ISOTOPES HAS INCREASED OWING TO THE RISING PREVALENCE OF TARGET DISEASES
8.5             OTHER END USERS

9.... STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY REGION

9.1             INTRODUCTION
9.2             NORTH AMERICA
9.2.1              US
9.2.1.1            THE US DOMINATES THE NORTH AMERICAN STABLE ISOTOPE-LABELED COMPOUNDS MARKET
9.2.2              CANADA
9.2.2.1            AVAILABILITY OF FUNDING WILL DRIVE THE MARKET IN CANADA
9.3             EUROPE
9.3.1              GERMANY
9.3.1.1            GERMANY IS THE FASTEST-GROWING MARKET IN EUROPE
9.3.2              UK
9.3.2.1            FAVORABLE SCENARIO FOR ENVIRONMENTAL RESEARCH AND INCREASING PREVALENCE OF CANCER ARE KEY GROWTH DRIVERS IN THE UK
9.3.3              FRANCE
9.3.3.1            FRANCE HAS A LARGE AND WELL-DEVELOPED BIOTECH INDUSTRY
9.3.4              ITALY
9.3.4.1            STRONG GOVERNMENT SUPPORT FOR RESEARCH HAS STIMULATED MARKET GROWTH IN ITALY
9.3.5              SPAIN
9.3.5.1            INCREASING RESEARCH ACTIVITIES AND EXPENDITURE SHOWS SIGNIFICANT MARKET GROWTH POTENTIAL IN SPAIN
9.3.6              REST OF EUROPE
9.4             ASIA PACIFIC
9.4.1              CHINA
9.4.1.1            CHINA DOMINATES THE STABLE ISOTOPE-LABELED COMPOUNDS MARKET IN THE APAC
9.4.2              JAPAN
9.4.2.1            GROWING SUPPORT AND FUNDING HAVE RAISED RESEARCH INTENSITY IN JAPAN
9.4.3              INDIA
9.4.3.1            GOVERNMENT INITIATIVES HAVE STRENGTHENED THE LIFE SCIENCE INDUSTRY IN INDIA
9.4.4              AUSTRALIA
9.4.4.1            GROWING FUNDING FOR RESEARCH AND COLLABORATIONS HAVE SUPPORTED MARKET GROWTH IN AUSTRALIA
9.4.5              REST OF ASIA PACIFIC
9.5             REST OF THE WORLD

10.. COMPETITIVE LANDSCAPE

10.1          OVERVIEW
10.2          MARKET SHARE ANALYSIS, 2018
10.3          COMPETITIVE SCENARIO
10.4          COMPETITIVE LEADERSHIP MAPPING (2018)
10.4.1            VISIONARY LEADERS
10.4.2            INNOVATORS
10.4.3            DYNAMIC DIFFERENTIATORS
10.4.4            EMERGING COMPANIES

11.. COMPANY PROFILES

(BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, COMPETITIVE ANALYSIS, MNM VIEW)*
11.1          CAMBRIDGE ISOTOPE LABORATORIES
11.2          MERCK KGAA
11.3          URENCO LIMITED
11.4          ISOSCIENCES
11.5          MEDICAL ISOTOPES
11.6          OMICRON BIOCHEMICALS
11.7          TRACE SCIENCES INTERNATIONAL
11.8          ALSACHIM
11.9          TAIYO NIPPON SANSO CORPORATION
11.10        PERKINELMER
11.11        ROTEM INDUSTRIES ISRAEL
11.12        BOC SCIENCES
11.13        CORTECNET
11.14        ISOFLEX
11.15        HUAYI ISOTOPES CO.
11.16        MESBAH ENERGY CO.
11.17        SHANGHAI RESEARCH INSTITUTE OF CHEMICAL INDUSTRY
11.18        13C MOLECULAR
11.19        C/D/N ISOTOPES
11.20        SHOKO CO.
*BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, COMPETITIVE ANALYSIS, MNM VIEW MIGHT NOT BE CAPTURED IN CASE OF UNLISTED COMPANIES.

12.. APPENDIX

LIST OF TABLES

TABLE 1              COMPANY DRUG PIPELINES, 2019
TABLE 2              TOP INVESTORS IN R&D, 2016 VS. 2017
TABLE 3              GLOBAL CANCER INCIDENCE, 2018 VS. 2025
TABLE 4              GOVERNMENT FUNDING PROGRAMS FOR PHARMACEUTICAL R&D IN EMERGING NATIONS   38
TABLE 5              STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 6              HYDROGEN-2-LABELED COMPOUNDS MARKET, BY REGION, 2017–2022 (USD MILLION)
TABLE 7              NORTH AMERICA: HYDROGEN-2-LABELED COMPOUNDS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 8              EUROPE: HYDROGEN-2-LABELED COMPOUNDS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 9              APAC: HYDROGEN-2-LABELED COMPOUNDS MARKET, BY COUNTRY, 2017–2024 (USD THOUSAND)
TABLE 10            CARBON-13-LABELED COMPOUNDS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 11            NORTH AMERICA: CARBON-13-LABELED COMPOUNDS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 12            EUROPE: CARBON-13-LABELED COMPOUNDS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 13            APAC: C CARBON-13-LABELED COMPOUNDS MARKET, BY COUNTRY, 2017–2024 (USD THOUSAND)
TABLE 14            OXYGEN-18-LABELED COMPOUNDS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 15            NORTH AMERICA: OXYGEN-18-LABELED COMPOUNDS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 16            EUROPE: OXYGEN-18-LABELED COMPOUNDS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 17            APAC: OXYGEN-18-LABELED COMPOUNDS MARKET, BY COUNTRY, 2017–2024 (USD THOUSAND) 47
TABLE 18            NITROGEN-15-LABELED COMPOUNDS MARKET, BY REGION, 2017–2022 (USD MILLION)
TABLE 19            NORTH AMERICA: NITROGEN-15-LABELED COMPOUNDS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 20            EUROPE: NITROGEN-15-LABELED COMPOUNDS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 21            APAC: NITROGEN-15-LABELED COMPOUNDS MARKET, BY COUNTRY, 2017–2024 (USD THOUSAND)
TABLE 22            OTHER STABLE ISOTOPES MARKET, BY REGION, 2017–2022 (USD THOUSAND)
TABLE 23            NORTH AMERICA: OTHER STABLE ISOTOPES MARKET, BY COUNTRY, 2017–2024 (USD THOUSAND)
TABLE 24            EUROPE: OTHER STABLE ISOTOPES MARKET, BY COUNTRY, 2017–2024 (USD THOUSAND)
TABLE 25            APAC: OTHER STABLE ISOTOPES MARKET, BY COUNTRY, 2017–2024 (USD THOUSAND)
TABLE 26            STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 27            STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2017–2024 (USD MILLION)
TABLE 28            NORTH AMERICA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 29            EUROPE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 30            APAC: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 31            STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR CLINICAL DIAGNOSTICS, BY REGION, 2017–2024 (USD MILLION)
TABLE 32            NORTH AMERICA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 33            EUROPE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 34            APAC: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2017–2024 (USD THOUSAND)
TABLE 35            STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR INDUSTRIAL APPLICATIONS, BY REGION, 2017–2024 (USD MILLION)
TABLE 36            NORTH AMERICA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 37            EUROPE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2017–2024 (USD THOUSAND)
TABLE 38            APAC: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2017–2024 (USD THOUSAND)
TABLE 39            STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR OTHER APPLICATIONS, BY REGION, 2017–2024 (USD MILLION)
TABLE 40            NORTH AMERICA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2017–2024 (USD THOUSAND)
TABLE 41            EUROPE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2017–2024 (USD THOUSAND)
TABLE 42            APAC: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2017–2024 (USD THOUSAND)
TABLE 43            STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2017–2024 (USD MILLION) 64
TABLE 44            STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2017–2024 (USD MILLION)
TABLE 45            NORTH AMERICA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 46            EUROPE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 47            APAC: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2017–2024 (USD THOUSAND)
TABLE 48            STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2017–2024 (USD MILLION)
TABLE 49            NORTH AMERICA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 50            EUROPE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 51            APAC: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2017–2024 (USD THOUSAND)
TABLE 52            STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2015–2022 (USD MILLION)
TABLE 53            NORTH AMERICA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2017–2024 (USD THOUSAND)
TABLE 54            EUROPE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2017–2024 (USD THOUSAND)
TABLE 55            APAC: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2017–2024 (USD THOUSAND)
TABLE 56            STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR OTHER END USERS, BY REGION, 2015–2022 (USD MILLION)
TABLE 57            NORTH AMERICA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR OTHER END USERS, BY COUNTRY, 2017–2024 (USD THOUSAND)
TABLE 58            EUROPE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR OTHER END USERS, BY COUNTRY, 2017–2024 (USD THOUSAND)
TABLE 59            APAC: STABLE ISOTOPE-LABELED COMPOUNDS MARKET FOR OTHER END USERS, BY COUNTRY, 2017–2024 (USD THOUSAND)
TABLE 60            STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 61            NORTH AMERICA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 62            NORTH AMERICA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 63            NORTH AMERICA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 64            NORTH AMERICA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 65            US: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 66            US: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 67            US: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 68            CANADA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2017–2024 (USD THOUSAND)
TABLE 69            CANADA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2017–2024 (USD THOUSAND)
TABLE 70            CANADA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2017–2024 (USD THOUSAND)
TABLE 71            EUROPE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 72            EUROPE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 73            EUROPE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 74            EUROPE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 75            GERMANY: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 76            GERMANY: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 77            GERMANY: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 78            UK: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 79            UK: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 80            UK: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 81            FRANCE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2017–2024 (USD THOUSAND)
TABLE 82            FRANCE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2017–2024 (USD THOUSAND)
TABLE 83            FRANCE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2015–2022 (USD THOUSAND)
TABLE 84            ITALY: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2017–2024 (USD THOUSAND)
TABLE 85            ITALY: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2017–2024 (USD THOUSAND)
TABLE 86            ITALY: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2017–2024 (USD THOUSAND)
TABLE 87            SPAIN: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2017–2024 (USD THOUSAND)
TABLE 88            SPAIN: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2017–2024 (USD THOUSAND)
TABLE 89            SPAIN: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2017–2024 (USD THOUSAND)
TABLE 90            PHARMACEUTICAL R&D EXPENDITURE IN ROE COUNTRIES (2016)
TABLE 91            ROE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2017–2024 (USD THOUSAND)
TABLE 92            ROE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2017–2024 (USD THOUSAND)
TABLE 93            ROE: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2017–2024 (USD THOUSAND)
TABLE 94            NUMBER OF NUCLEAR REACTORS IN THE ASIA PACIFIC (AUGUST 2019)
TABLE 95            ASIA PACIFIC: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 96            ASIA PACIFIC: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 97            ASIA PACIFIC: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 98            ASIA PACIFIC: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2015–2022 (USD MILLION)
TABLE 99            CHINA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 100          CHINA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 101          CHINA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 102          JAPAN: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2017–2024 (USD THOUSAND)
TABLE 103          JAPAN: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2015–2022 (USD THOUSAND)
TABLE 104          JAPAN: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2017–2024 (USD THOUSAND)
TABLE 105          INDIA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2017–2024 (USD THOUSAND)
TABLE 106          INDIA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2017–2024 (USD THOUSAND)
TABLE 107          INDIA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2017–2024 (USD THOUSAND)
TABLE 108          AUSTRALIA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2017–2024 (USD THOUSAND)
TABLE 109          AUSTRALIA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2017–2024 (USD THOUSAND)
TABLE 110          AUSTRALIA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2017–2024 (USD THOUSAND)
TABLE 111          ROAPAC: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2017–2024 (USD THOUSAND)
TABLE 112          ROAPAC: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2017–2024 (USD THOUSAND)
TABLE 113          ROAPAC: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2017–2024 (USD THOUSAND)
TABLE 114          ROW: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2017–2024 (USD THOUSAND)
TABLE 115          ROW: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2017–2024 (USD THOUSAND)
TABLE 116          ROW: STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2017–2024 (USD THOUSAND)
TABLE 117          AGREEMENTS (2016–2019)
TABLE 118          PRODUCT LAUNCHES (2016-2019)

 

FIGURE 1            RESEARCH DESIGN
FIGURE 2            BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 3            RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
FIGURE 4            MARKET SIZE ESTIMATION: STABLE ISOTOPE-LABELED COMPOUNDS MARKET
FIGURE 5            MARKET DATA TRIANGULATION METHODOLOGY
FIGURE 6            STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY TYPE, 2019 VS. 2024 (USD MILLION) 29
FIGURE 7            STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY APPLICATION, 2019 VS. 2024 (USD MILLION)
FIGURE 8            STABLE ISOTOPE-LABELED COMPOUNDS MARKET, BY END USER, 2019 VS. 2024 (USD MILLION)
FIGURE 9            GEOGRAPHIC SNAPSHOT OF THE STABLE ISOTOPE-LABELED COMPOUNDS MARKET
FIGURE 10          INCREASE IN RESEARCH IN THE PHARMACEUTICAL & BIOTECHNOLOGY SECTORS WILL DRIVE MARKET GROWTH
FIGURE 11          RESEARCH APPLICATIONS ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN MARKET IN 2018
FIGURE 12          NORTH AMERICA TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD   34
FIGURE 13          STABLE ISOTOPE-LABELED COMPOUNDS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 14          NORTH AMERICA: STABLE ISOTOPE-LABELED COMPOUNDS MARKET SNAPSHOT
FIGURE 15          ASIA PACIFIC: STABLE ISOTOPE-LABELED COMPOUNDS MARKET SNAPSHOT
FIGURE 16          MARKET RANKING OF KEY PLAYERS, 2018
FIGURE 17          COMPETITIVE LEADERSHIP MAPPING: STABLE ISOTOPE-LABELED COMPOUNDS MARKET
FIGURE 18          MERCK KGAA: COMPANY SNAPSHOT
FIGURE 19          URENCO LIMITED: COMPANY SNAPSHOT (2018)
FIGURE 20          TAIYO NIPPON SANSO CORPORATION: COMPANY SNAPSHOT (2018)
FIGURE 21          PERKINELMER: COMPANY SNAPSHOT (2018)

当レポートのプレスリリースは発行されておりません。